000 | 01056 a2200301 4500 | ||
---|---|---|---|
005 | 20250513220901.0 | ||
264 | 0 | _c20010301 | |
008 | 200103s 0 0 eng d | ||
022 | _a1351-8216 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRubinger, M | |
245 | 0 | 0 |
_aSuggestions for the management of factor VIII inhibitors. _h[electronic resource] |
260 |
_bHaemophilia : the official journal of the World Federation of Hemophilia _cJul 2000 |
||
300 |
_a52-9 p. _bdigital |
||
500 | _aPublication Type: Guideline; Journal Article; Practice Guideline | ||
650 | 0 | 4 | _aClinical Protocols |
650 | 0 | 4 | _aDecision Trees |
650 | 0 | 4 | _aDisease Management |
650 | 0 | 4 |
_aFactor VIII _xantagonists & inhibitors |
650 | 0 | 4 |
_aHemophilia A _xcomplications |
650 | 0 | 4 |
_aHemorrhage _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoantibodies _xblood |
700 | 1 | _aRivard, G E | |
700 | 1 | _aTeitel, J | |
700 | 1 | _aWalker, H | |
773 | 0 |
_tHaemophilia : the official journal of the World Federation of Hemophilia _gvol. 6 Suppl 1 _gp. 52-9 |
|
999 |
_c10929542 _d10929542 |